<DOC>
	<DOCNO>NCT01557699</DOCNO>
	<brief_summary>This phase I , open-label , randomize study healthy adult . Eligible subject give single dose either Dry Powdered Measles Vaccine ( PMV ) Puffhaler® device , Dry PMV SoloventTM device license measles vaccine subcutaneous route ( SMV ) . Subjects follow 180 day safety .</brief_summary>
	<brief_title>A Clinical Trial Assess Safety Measles Vaccine ( Dry Powder ) Administered Two Different Devices</brief_title>
	<detailed_description>This phase I , open-label , randomize study healthy adult . Eligible subject give single dose either Dry Powdered Measles Vaccine ( PMV ) Puffhaler® device , Dry PMV SoloventTM device license measles vaccine subcutaneous route ( SMV ) . Solicited reaction assess first 14 day vaccination unsolicited adverse event assess till 84 day vaccination . Subjects follow 180 day SAEs .</detailed_description>
	<mesh_term>Measles</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male adult age 1845 year . Measles immune , determine IgG antibody level . Healthy support medical history , physical examination laboratory evaluation preset parameter . Signed informed consent participation trial HIV screening . Medical history immunodeficiency/suppression subject history close contact immunocompromised/ immunosuppressed person . Chronic administration immunosuppressant immune modify agent Acute febrile illness suspect measles illness acute infectious disease Acute chronic , clinically significant pulmonary , endocrine , autoimmune , psychiatric , cardiovascular , neurological , hepatic renal functional abnormality opinion investigator , might interfere study objective History seizure disorder Major congenital defect Thrombocytopenia know bleed disorder 8 . History previous severe allergic reaction Positive serology HIV antibody , HCV antibody Hepatitis B surface antigen Known hypersensitivity component study vaccine</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>